Funded Tech Companies

Complement Therapeutics

Complement Therapeutics is a biopharmaceutical tech venture, based in London England. VC investment was provided by Panakes Partners, BioGeneration Ventures and Hadean Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/17/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rafiq Hasan

        

Chief Scientific Officer

Dennis Keefe

        

Founder

Paul Bishop

        

Founder

Simon Clark

        

Founder

Richard Unwin

        

Company Investors

• Panakes Partners (Rob Woodman)
• BioGeneration Ventures
• Hadean Ventures (Roger Franklin)
• Forbion Capital Partners
• Cambridge Innovation Capital (Anne Horgan)
• Seroba Life Sciences
• GIMV (Michaël Vlemmix)

Browse more funded tech companies:

Complai | Complete

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary